Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Promise of Biomarkers in Diagnosing Major Depression in Primary Care: the Present and Future
Eva E. Redei, Neha S. Mehta
Current Psychiatry Reports (2015) Vol. 17, Iss. 8
Closed Access | Times Cited: 19

Showing 19 citing articles:

Suggested Biomarkers for Major Depressive Disorder
Yunus Hacımusalar, Ertuğrul Eşel
Nöro Psikiyatri Arşivi (2017)
Open Access | Times Cited: 98
The link between long noncoding RNAs and depression
Xiao Huang, Yanli Luo, Yue-Shi Mao, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 73, pp. 73-78
Closed Access | Times Cited: 86
Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress
Josephine C. McGowan, Collin Hill, Alessia Mastrodonato, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 9, pp. 1813-1821
Open Access | Times Cited: 53
Lower inflammatory markers in women with antenatal depression brings the M1/M2 balance into focus from a new direction
Åsa Edvinsson, Emma Bränn, Charlotte Hellgren, et al.
Psychoneuroendocrinology (2017) Vol. 80, pp. 15-25
Open Access | Times Cited: 51
The Wistar Kyoto Rat: A Model of Depression Traits
Eva E. Redei, Mallory E. Udell, Leah C. Solberg Woods, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 9, pp. 1884-1905
Open Access | Times Cited: 16
Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles
Man K. Chan, Jason D. Cooper, Sabine Bahn
Trends in biotechnology (2015) Vol. 33, Iss. 12, pp. 712-723
Closed Access | Times Cited: 25
Identification of commonly altered genes between in major depressive disorder and a mouse model of depression
Hirotaka Yamagata, Shusaku Uchida, Koji Matsuo, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 25
Current challenges and possible future developments in personalized psychiatry with an emphasis on psychotic disorders
Аnastasia Levchenko, Timur Nurgaliev, Alexander Kanapin, et al.
Heliyon (2020) Vol. 6, Iss. 5, pp. e03990-e03990
Open Access | Times Cited: 22
Violence and depression in a community sample
Pilar Montesó‐Curto, Carina Aguilar, Marylène Lejeune, et al.
Journal of Clinical Nursing (2016) Vol. 26, Iss. 15-16, pp. 2392-2398
Closed Access | Times Cited: 22
The functional variant rs334558 of <em>GSK3B</em> is associated with remission in patients with depressive disorders
Аnastasia Levchenko, Innokentiy S. Losenkov, N. Vyalova, et al.
Pharmacogenomics and Personalized Medicine (2018) Vol. Volume 11, pp. 121-126
Open Access | Times Cited: 15
Premature hippocampus-dependent memory decline in middle-aged females of a genetic rat model of depression
Patrick H. Lim, Stephanie L. Wert, Elif Tunc‐Ozcan, et al.
Behavioural Brain Research (2018) Vol. 353, pp. 242-249
Closed Access | Times Cited: 14
Biomarkers
Jorge Manzanares, F. Sala, María Salud García Gutiérrez, et al.
Elsevier eBooks (2021), pp. 693-724
Closed Access | Times Cited: 8
Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders
Zoltán Sarnyai, Paul C. Guest
Advances in experimental medicine and biology (2017), pp. 97-114
Closed Access | Times Cited: 6
Alteration of transthyretin and thyroxine-binding globulin in major depressive disorder: multiple reaction monitoring-based proteomic analysis
Hye In Woo, Jisook Park, Shinn‐Won Lim, et al.
Journal of Translational Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 5
Determinación de serotonina plasmática y otros neurotransmisores en el diagnóstico de la depresión: Evidencia y falsedades
Enric Aragonés
FMC - Formación Médica Continuada en Atención Primaria (2020) Vol. 27, Iss. 3, pp. 131-133
Closed Access | Times Cited: 2
Impaired mitochondrial bioenergetics in psychiatric disorders
Péter Petschner, Zsófia Gál, Xénia Gonda
Clinical bioenergetics (2020), pp. 195-221
Closed Access | Times Cited: 1
Alteration of Transthyretin and Thyroxine-Binding Globulin in Major Depressive Disorder: Multiple Reaction Monitoring-Based Proteomic Analysis
Hye In Woo, Jisook Park, Shinn‐Won Lim, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Alteration of Transthyretin and Thyroxine-Binding Globulin in Major Depressive Disorder: Multiple Reaction Monitoring-Based Proteomic Analysis
Hye In Woo, Jisook Park, Shinn‐Won Lim, et al.
Research Square (Research Square) (2020)
Open Access
Alteration of Transthyretin and Thyroxine-Binding Globulin in Major Depressive Disorder: Multiple Reaction Monitoring-Based Proteomic Analysis
Hye In Woo, Jisook Park, Shinn‐Won Lim, et al.
Research Square (Research Square) (2021)
Open Access
Page 1

Scroll to top